The business value of technologies such as at-home diagnostics, remote clinical monitoring, and wearables increased substantially as patients isolated at home and providers shifted to digital patient monitoring. Widespread adoption of these technologies increased data collection to prove their effectiveness. Providers and health insurers should invest in these technologies, offer subsidies to patients and members to drive adoption, and enable the shift from reactive to proactive engagement. Clients can schedule an inquiry to see if their efforts are on track.